Evolution of the Average Target: Compugen Ltd.

Evolution of the Target Price: Compugen Ltd.

Changes in Analyst Recommendations: Compugen Ltd.

e48ee01887553f06614b0c8238.OUhDggIA-JjgOCOwyG8IXuCzSN16RnV5oDIOfDVzxbw.FDwEzkFTkNGKV0XfmCtEDKTReKw4IC8Y43g7JkAlgt1XMHPgRzfA8apyVA~1e16068a2f3dc492b18460cdfdb8336e
01-07 HC Wainwright Initiates Compugen at Buy With $4 Price Target MT
13/10/25 Compugen Ltd. to Present Pooled Analysis of COM701 in Three Phase 1 Trials in Patients with Platinum Resistant Ovarian Cancer at ESMO 2025 CI
20/05/24 Truist Securities Trims Price Target on Compugen to $4 From $5, Maintains Buy Rating MT
08/03/24 Truist Securities Adjusts Price Target on Compugen to $5 From $4, Maintains Buy Rating MT
16/05/23 Oppenheimer Adjusts Compugen's Price Target to $7 From $8, Maintains Outperform Rating MT
08/02/23 Jefferies Downgrades Compugen to Underperform From Hold, Lowers Price Target to $0.50 from $2 MT
05/01/23 EF Hutton Initiates Compugen at Buy With $13 Price Target MT
15/11/22 Oppenheimer Adjusts Compugen PT to $8 From $12, Updates Model to Reflect Evolving Development Strategy; Maintains Outperform Rating MT
23/08/22 Truist Securities Adjusts Compugen's Price Target to $4 From $14, Reiterates Buy Rating MT
08/08/22 JMP Securities Adjusts Price Target on Compugen to $4 From $8, Maintains Market Outperform Rating MT
05/08/22 Oppenheimer Adjusts Compugen Price Target to $12 From $14, Maintains Outperform Rating MT
05/08/22 Stifel Adjusts Compugen's Price Target to $5 From $12, Reiterates Buy Rating MT
05/08/22 Jefferies Downgrades Compugen to Hold From Buy; Price Target is $2 MT
25/02/22 SVB Leerink Adjusts Compugen's Price Target to $9 from $16, Maintains Outperform Rating MT
25/02/22 Oppenheimer Adjusts Compugen's Price Target to $14 From $17, Maintains Outperform Rating MT
15/11/21 Oppenheimer Adjusts Compugen PT to $17 From $19, Maintains Outperform Rating MT
06/04/21 COMPUGEN : SVB Leerink Adjusts Price Target on Compugen to $16 From $19, Maintains Outperform Rating MT

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+97%
+19.38%
+14.78%
+7.72%
+29.05%
+39.59%
+21.26%
+0.61%
+11.01%
+5.83%
Average +24.62%
Weighted average by Cap. +18.43%
See all sector consensus

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
2.350USD
Average target price
4.600USD
Spread / Average Target
+95.74%
High Price Target
6.000USD
Spread / Highest target
+155.32%
Low Price Target
4.000USD
Spread / Lowest Target
+70.21%

Analyst Consensus Detail

Consensus revision (last 18 months)

Analysts covering the company

HC Wainwright
Truist Securities
Oppenheimer
Jefferies & Co.
EF Hutton
JMP Securities
Stifel Nicolaus
SVB Leerink
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
2.350USD
Average target price
4.600USD
Spread / Average Target
+95.74%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. CGEN Stock
  4. Consensus Compugen Ltd.